Malaria Gets its Second Vax: Why it’s Momentous
Oct 05, 2023•6 min•Ep. 234
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
A malaria vaccine developed by Oxford University and Serum Institute of India (SII) has been recommended for large-scale use by the World Health Organization (WHO). The R21/Matrix-M—only the second malaria jab—has shown up to 75% efficacy.
For the best experience, listen in Metacast app for iOS or Android